A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.

Background: Clinical pharmacists have demonstrated their ability to improve patient outcomes over usual care for patients with type 2 diabetes and glycemic levels above goal, though reasons for this are not well defined. Numerous medications exist for the management of patients with type 2 diabetes and different patterns of medication use by clinical pharmacists may explain these benefits.

Objective: The objective of this study was to compare pharmacotherapy approaches to managing patients with uncontrolled type 2 diabetes receiving basal insulin by a clinical pharmacist versus usual care by a physician or advanced practice provider in a federally qualified health center.

Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy.

Objective: To evaluate patient satisfaction with pharmacist-administered long-acting injectable antipsychotics (LAIAs) in the community pharmacy.

Design: Prospective survey.

Setting: Albertsons Companies community pharmacies during December 2016 to February 2017.